Insiders · PMCB

Jonathan Schechter

Director at PharmaCyte Biotech, Inc. (PMCB) since August 2022

Jonathan Schechter has filed 22 insider reports with the SEC since June 2021, as director at PharmaCyte Biotech, Inc. (PMCB), director at Oblong, Inc. (TWAV) and director at TAO Synergies Inc. (TAOX). In the last 12 months Jonathan Schechter bought $48.2K of stock on the open market. The latest filing, on July 17, 2026, reports other acquisition or disposition at PharmaCyte Biotech, Inc. (PMCB).

Filings
22
Companies
3
Bought on market
$108K
Sold on market
$23.7K

Companies where Jonathan Schechter is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
PharmaCyte Biotech, Inc. logo
PMCB
PharmaCyte Biotech, Inc.
Directorsince August 2022192,500$48.2K$0.80$5.42+578%Jul 17, 2026
Oblong, Inc. logo
TWAV
Oblong, Inc.
Directorsince May 202325,000$59.9K$2.40$1.17-51%Nov 17, 2025
TAO Synergies Inc. logo
TAOX
TAO Synergies Inc.
Directorsince June 202114,035$23.7K$1.87Oct 17, 2025

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.

Every filing

Also sits on boards with

Officers and directors who share two or more companies with Jonathan Schechter.

Compare Jonathan Schechter with

Other insiders at the same companies

Questions about Jonathan Schechter

What is Jonathan Schechter's role at PharmaCyte Biotech, Inc.?
Jonathan Schechter reports to the SEC as director at PharmaCyte Biotech, Inc. (PMCB), according to the latest filing on July 17, 2026. Jonathan Schechter has also filed as director at Oblong, Inc. (TWAV) and director at TAO Synergies Inc. (TAOX).
How many shares does Jonathan Schechter own?
After the latest filing that states it, Jonathan Schechter directly owned 192,500 shares of PharmaCyte Biotech, Inc. (PMCB), 25,000 shares of Oblong, Inc. (TWAV) and 14,035 shares of TAO Synergies Inc. (TAOX). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Jonathan Schechter bought or sold stock recently?
The most recent open-market purchase was on January 7, 2026: bought 60,000 shares of PharmaCyte Biotech, Inc. (PMCB) for $48.2K at an average of $0.80. The most recent open-market sale was on December 16, 2022: sold 20,250 shares of Synaptogenix, Inc. (TAOX) for $23.7K at an average of $1.17.
How do I get alerts when Jonathan Schechter files?
Follow Jonathan Schechter on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Jonathan Schechter (SEC CIK 0001619259). Totals count each trade once, skipping amendments whose original is on file, from Jun 15, 2021 on. View on SEC EDGAR